Are you up to date on the components of an antineoplastic safety program? Examine your policies during this session on developing a comprehensive safety and health program, including engineering controls, competent personnel, safe work practices, personal protective equipment, evidence-based policies and procedures, and a medical surveillance program. You’ll review case studies on environmental and personnel monitoring and learn the actions you can take to minimize the adverse effects of exposure.
Objectives1. Summarize recent and historical evidence for healthcare workers’ exposure to antineoplastic drugs.
2. Analyze the components of a safety and health program in one’s workplace aimed at preventing environmental contamination and personnel exposure to antineoplastic drugs.
3. Develop a plan to implement a medical surveillance program for staff who are exposed occupationally to antineoplastic agents.
ILNAThis session qualifies for the following ONCC Individual Learning Needs Assessment (ILNA) categories.
OCN®: Treatment Modalities
CBCN®: Treatment Modalities
AOCNP®: Cancer Treatment
AOCNS®: Cancer Treatment
BMT™: Professional Practice
